News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Integrating Newer Therapies into Management of Adult ALL

EP. 1: Prognostic Factors Which Impact ALL Management

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 13th 2021

EP. 2: Treating Young Adult Patients With Philadelphia Chromosome–Positive ALL

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 13th 2021

EP. 3: Treating Older Adult Patients With Philadelphia Chromosome-Positive ALL

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 13th 2021

EP. 4: Treating Young Adult Patients With Philadelphia Chromosome-Negative ALL

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 21st 2021

EP. 5: Treating Older Adult Patients With Philadelphia Chromosome-Negative ALL

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 28th 2021

EP. 6: Role of MRD Testing in Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

January 28th 2021

EP. 7: Treatment of Acute Lymphoblastic Leukemia in the Community Setting

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 4th 2021

EP. 8: Managing MRD-Positive Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 4th 2021

EP. 9: Managing MRD-Negative Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 11th 2021

EP. 10: Role of Transplant in Older Adults With Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 11th 2021

EP. 11: Approach to Managing Relapsed Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 18th 2021

EP. 12: CAR T-Cell Therapy After First Relapse of Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 18th 2021

EP. 13: CAR T-Cell Therapy Use in Second Line Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 25th 2021

EP. 14: Investigational CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

February 25th 2021

EP. 15: Evolving Field of Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

March 4th 2021

EP. 16: ASH Updates for CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

ByRichard M. Stone, MD, Dana-Farber Cancer Institute,Ryan D. Cassaday, MD, University of Washington/Fred Hutch,Jae Park, MD, Memorial Sloan Kettering Cancer Center,Bijal Shah, MD, Moffit Cancer Center

March 4th 2021

Trending on OncLive

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL